RSPKX
Price
$23.39
Change
+$0.17 (+0.73%)
Updated
Jul 25 closing price
Net Assets
538.04M
VSIAX
Price
$87.39
Change
+$0.46 (+0.53%)
Updated
Jul 25 closing price
Net Assets
55.61B
Interact to see
Advertisement

RSPKX vs VSIAX

Header iconRSPKX vs VSIAX Comparison
Open Charts RSPKX vs VSIAXBanner chart's image
Victory RS Partners R
Price$23.39
Change+$0.17 (+0.73%)
VolumeN/A
Net Assets538.04M
Vanguard Small Cap Value Index Admiral
Price$87.39
Change+$0.46 (+0.53%)
VolumeN/A
Net Assets55.61B
RSPKX vs VSIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RSPKX vs. VSIAX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSPKX is a Buy and VSIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 55.6B vs. RSPKX (538M). VSIAX pays higher dividends than RSPKX: VSIAX (2.11) vs RSPKX (0.03). RSPKX was incepted earlier than VSIAX: RSPKX (19 years) vs VSIAX (14 years). RSPKX (2.42) is less costly to investors than VSIAX (0.07). RSPKX is a more actively managed with annual turnover of: 48.00 vs. VSIAX (16.00). RSPKX has a lower initial minimum investment than VSIAX: RSPKX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 5.59 vs. RSPKX (-3.75). VSIAX return over 5 years is better than : 88.99 vs. RSPKX (39.35).
RSPKXVSIAXRSPKX / VSIAX
Total Expense Ratio1.690.072,414%
Annual Report Gross Expense Ratio2.420.073,457%
Fund Existence19 years14 years-
Gain YTD-1.0582.904-36%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets538M55.6B1%
Annual Yield % from dividends0.032.112%
Returns for 1 year-3.755.59-67%
Returns for 3 years8.0031.0826%
Returns for 5 years39.3588.9944%
Returns for 10 years-15.69102.83-15%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBIO46.280.62
+1.36%
BridgeBio Pharma
VIRT44.200.43
+0.98%
Virtu Financial Inc
NYMTN21.61N/A
N/A
New York Mortgage Trust
ARCT14.94-0.01
-0.07%
Arcturus Therapeutics Holdings
CELU2.96-0.20
-6.33%
Celularity